Ron Squarer
2015
In 2015, Ron Squarer earned a total compensation of $4.1M as Chief Executive Officer at Array BioPharma, a 86% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $343,262 |
|---|---|
| Option Awards | $1,954,337 |
| Salary | $558,250 |
| Stock Awards | $1,170,438 |
| Other | $46,661 |
| Total | $4,072,948 |
Squarer received $2M in option awards, accounting for 48% of the total pay in 2015.
Squarer also received $343.3K in non-equity incentive plan, $558.3K in salary, $1.2M in stock awards and $46.7K in other compensation.
Rankings
In 2015, Ron Squarer's compensation ranked 2,128th out of 13,638 executives tracked by ExecPay. In other words, Squarer earned more than 84.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,128 out of 13,638 | 84th |
Division Manufacturing | 763 out of 5,190 | 85th |
Major group Chemicals And Allied Products | 276 out of 1,854 | 85th |
Industry group Drugs | 218 out of 1,528 | 86th |
Industry Pharmaceutical Preparations | 174 out of 1,182 | 85th |
Source: SEC filing on September 13, 2017.
Squarer's colleagues
We found five more compensation records of executives who worked with Ron Squarer at Array BioPharma in 2015.